PharmExec Direct:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile
PharmExec Direct | From the editors of Pharmaceutical Executive Visit the PharmExec website
Send Us Some Feedback
 
July 28, 2011 | ISSUE NUMBER 210 VOL 8


M&As
Generics Win in Express Scripts/Medco Deal?
As a preferred generics supplier to Medco’s mail-order business, Novartis’ Sandoz division should be waiting with bated breath—and champagne at the ready—for an FTC approval of Express Scripts’ proposed $29.1 billion acquisition of Medco ...Read more

Economy
Debt Ceiling and Debt Reduction: An Unwelcome Rx
for Pharma

As the White House and Congress battle the looming deadline to raise the country’s debt ceiling, what are the potential implications of the various debt-reduction proposals on the pharmaceutical industry? ...Read more

Legislation
Uncle Sam Wants YOU to Help Reduce Spending
Republicans and Democrats both agree that spending cuts should be part of next week’s budget deal, and some Democrats have expressed willingness to find opportunities for savings in Medicare and Medicaid. But these programs might now be spending less money if one bill on the Senate’s calendar had passed when it was originally introduced ...Read More

Advertisement
Join the Pharma Faceoff debate. Can the iPad really transform the pharma industry or is it a tech fad that will burst like the dot-com bubble?http://www.pharmafaceoff.com/episodes/can-the-ipad-save-sales

Global
FDA Finding Fuels Indian Crackdown on
Substandard Medicines

The findings of a routine monthly inspection by FDA in the state of Maharashtra last month has added extra pressure to India’s efforts to address the issue of substandard drugs ...Read more

Sales and Marketing
Can the iPad Save Pharma Sales? Part II
In the second episode of this Pharma Faceoff, the panel tackles the tricky questions: What kind of data are iPads collecting? What does physician adoption of iPhones and iPads mean for pharma? And, can iPads actually reverse the trend toward shrinking access? ...Click to Watch

// Sanofi-Aventis has recruited Anne Whitaker as President of its US pharmaceutical operations. Whitaker joins from GlaxoSmithKline, where she worked for almost 20 years and served as Senior VP and business head of its cardiovascular, metabolic and urology unit. // Aegerion Pharmaceuticals (Cambridge, Mass.) appointed Paul G. Thomas, Founder and Chief Executive Officer of Roka Bioscience (Warren, N.J.), to its Board of Directors, effective Aug. 1. Thomas will also serve as a member of the Audit Committee. The Board also announced the resignation of Michele Ollier as a Director, effective Aug. 1. // Publicis Touchpoint Solutions (Yardley, Pa.), a provider of multichannel message delivery solutions for the life sciences industry, announced that Maria K. Woods joined the organization as Director, Compliance and Privacy. // Healthcare Regional Marketing (Cincinnati), a marketing services company, announced that Seth Houston and Gabriel Nero have joined its team, as Vice President of Innovation and Product Development, and Vice President of Healthcare Markets, respectively. //

Sept. 15–16: Life Sciences Commercial IT Summit
Philadelphia, PA

Sept. 20–21: Strategic Pipeline Planning and Resource Allocation Summit
Philadelphia, PA

Sept. 26–27: Pharma/Bio Forum on Preclinical Development
Boston, MA


Oct. 14: L2 Clinic The Social Graph: Pharma
New York, NY


 
FindPharma  
Search  

 
Survey
If you were developing a biosimilar product, what would be your biggest concern?
Click To Vote
 
Quick Links

Europe Moves into an HTA Fray

The Latest on Europe's Falsified Medicines Directive

AIDS Drug Discounts Threatened


Follow Pharm Exec on Twitter
Follow Pharm Exec on Facebook

User Management
| Subscribe | Update My Profile | Send Feedback | Advertise With Us | Visit PharmExec.com |

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.

 
Visit Pharmaceutical Executive